首页> 外文期刊>BMC Ophthalmology >Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity
【24h】

Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity

机译:光学质量分析系统的效用在ND决策中的决策:YAG激光后帽患者患者患者患者

获取原文
           

摘要

A prospective cohort study was performed to evaluate whether the Optical Quality Analysis System (OQAS) can serve as a valuable additional indicator for appropriate posterior capsulotomy referral. One hundred and five eyes from 96 patients undergoing capsulotomy were divided into precapsulotomy logMAR CDVA ≤0.1 group and logMAR CDVA ?0.1 group. CDVA, and the Visual Function 14 index (VF-14) score were estimated before and 1?month after capsulotomy. The objective scattering index (OSI) value was measured by using the OQAS. Posterior capsule opacification (PCO) severity was assessed with Evaluation of PCO 2000 (EPCO 2000) software. In logMAR CDVA ?0.1 group, the correlations of OSI, logMAR CDVA, EPCO score and VF-14 score were very strong preoperatively. In logMAR CDVA ≤0.1 group, preoperatively, OSI was correlated with logMAR CDVA (r?=?0.451), EPCO score (r?=?0.789), and VF-14 score (r?=?0.852). LogMAR CDVA has weak correlation with VF-14 score (r?=???0.384) and EPCO score (r?=?0.566). VF-14 score was correlated with EPCO score (r?=???0.669). In the logMAR CDVA ≤0.1 group, there was no significant difference in logMAR CDVA between precapsulotomy and postcapsulotomy (P??0.05). In the two groups, all the other optical quality parameters were significantly improved after capsulotomy (P 0.1 group, the area under the curve of the ROC of the OSI was 0.996 (P?=?0.000). In logMAR CDVA ≤0.1 group, the area under the curve of the ROC of the OSI was 0.943 (P?=?0.000). The OSI was useful for evaluating of PCO and prediction of beneficial capsulotomy. Especially for patients with slight PCO and better visual acuity, OSI is more valuable than CDVA and completely objective examination. The study protocol was registered at the Chinese Clinical Trial Registry. Register: ChiCTR1800018842 (Registered Date: October 13th, 2018).
机译:进行潜在的队列研究以评估光学质量分析系统(OQAs)是否可以作为适当的后涂层素转诊的有价值的额外指示剂。从96名接受胶囊术术患者的一百五只眼睛分为渗透术logmarcdva≤0.1组和logmar cdva& 0.1组。 CDVA和Visual Function 14指数(VF-14)评分估计在葫芦术之前和1个月。通过使用OQAS测量目标散射指数(OSI)值。通过评估PCO 2000(EPCO 2000)软件评估后胶囊渗透率(PCO)严重程度。在logmar cdva& 0.1组,OSI,Logmar CDVA,EPCO评分和VF-14得分的相关性术前非常强烈。在Logmar CDVA≤0.1组中,术前,OSI与Logmar CDVA(R?= 0.451),EPCO评分(R?= 0.789)和VF-14得分(R?= 0.852)。 Logmar CDVA与VF-14得分有弱相关(R?= ??? 0.384)和EPCO评分(R?= 0.566)。 VF-14得分与EPCO评分相关(R?= ??? 0.669)。在Logmarcdva≤0.1组中,牙胚间术和脓肿术之间的Logmar CDVA没有显着差异(P?& 0.05)。在两组中,胶囊术后,所有其他光学质量参数都显着改善(P 0.1组,OSI的ROC曲线下的面积为0.996(p?= 0.000)。在LogmarCDVA≤0.1组中, OSI的ROC曲线下的区域为0.943(p?= 0.000)。OSI对评估PCO和预测有益胶囊术。特别是对于患有轻微PCO和更好的视力的患者,OSI比患者更有价值CDVA和完全客观的检查。研究方案在中国临床试验登记处注册。注册:CHICTR1800018842(注册日期:2018年10月13日)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号